Wockhardt's investigational drug, Zaynich demonstrates its ability to manage complex infections

In the past year, Wockhardt's investigational drug, Zaynich (Zidebactam/Cefepime), has successfully treated over 35 critically ill patients in India and US who were suffering from extremely drug-resistant infections under compassionate use. This drug